Suchergebnisse - "Butcher, Neville J"

PubPharm (71)

1

The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction

enthalten in: Pharmacological reviews | 2024

von Choudhury, C. | Gill, M. | McAleese, C. | +4

2

Lipidated brush-PEG polymers as low molecular weight pulmonary drug delivery platforms

enthalten in: Expert opinion on drug delivery | 2024

von Kaminskas, L. | Butcher, N. | Subasic, C. | +8

3

Acid-sensing ion channel 1a blockade reduces myocardial injury in rodent models of myocardial infarction

enthalten in: European heart journal | 2023

von Redd, M. | Yoshikawa, Y. | Khan, N. | +16

4

Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats

enthalten in: Molecular pharmaceutics | 2023

von Subasic, C. | Butcher, N. | Simpson, F. | +2

5

Contrasting Effects of Temperature on Human Arylamine N-Acetyltransferase and Acetyl Coenzyme A Hydrolase Activities

enthalten in: Biochemistry | 2023

von Choudhury, C. | McAleese, C. | Butcher, N. | +1

6

Arylamine N-acetyltransferase-1 reveals a subpopulation of ALS patients with altered metabolic capacity

enthalten in: bioRxiv.org | 2023

von Choudhury, C. | Allen, S. | Gill, M. | +6

7

Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats

enthalten in: Molecular pharmaceutics | 2023

von Subasic, C. | Butcher, N. | Minchin, R. | +1

8

Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration

enthalten in: Expert opinion on drug delivery | 2023

von Ibrahim, J. | Butcher, N. | Kothapalli, A. | +5

9

Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells : switch from cytochrome C-dependent apoptosis to necroptosis

enthalten in: Breast cancer research and treatment | 2022

von McAleese, C. | Butcher, N. | Minchin, R.

10

Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis

enthalten in: Breast cancer research and treatment | 2022

von McAleese, C. | Butcher, N. | Minchin, R.

1
2
3
4
5
6
7
8
Nächster »
[8]